William D Chey (W D Chey, William Chey)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Irritable Bowel Syndrome

Replacement Therapy

Helicobacter Pylori Infection

Top Venues

Therapeutic advances in gastroenterology

Alimentary pharmacology & therapeutics

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony J Lembo, Susan Edelstein, David P Rosenbaum, Ceciel Rooker, Jeffrey D Roberts, William D Chey
Long-term safety of tenapanor in people with irritable bowel syndrome with constipation from the T3MPO-3 study: plain language summary of publication. Therapeutic advances in gastroenterology 17 (2024)
Jonathan L Golob, Krishna Rao, Jeffrey A Berinstein, William D Chey, Chung Owyang, Nobuhiko Kamada, Peter D R Higgins, Vincent B Young, Shrinivas Bishu, Allen Lee
The Fecal Microbiome in Quiescent Crohn's Disease with Persistent Gastrointestinal Symptoms Show Enrichment of Oral Microbes But Depletion of Butyrate and Indole Producers. medRxiv : the preprint server for health sciences (2023)
William D Chey, Eric D Shah, Herbert L DuPont
Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. Therapeutic advances in gastroenterology 13 (2020)
Stacy Menees, William D Chey
The gut microbiome and irritable bowel syndrome. F1000Research 7 (2018)
Eric D Shah, William D Chey
Editorial: recurrence of Helicobacter pylori infection-still the same after all these years…. Alimentary pharmacology & therapeutics 47 (1) (2017)
William D Chey, L S Dove, D A Andrae, P S Covington
Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies. Alimentary pharmacology & therapeutics 45 (10) (2017)